F.D.A. Rushed a Drug for Preterm Births. Did It Put Speed Over Science? - The New York Times

The agency’s accelerated approval program for certain drugs has come under intense scrutiny because some medicines stay on the market despite limited evidence that they work.

So the bottom line is that the accelerated approval regulations worked, Mr. Harrington said. They helped draw more companies into the space. They led to the discovery of effective treatments. Yet Mr… [+1465 chars]

full article...